BE809832A - PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES - Google Patents

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES

Info

Publication number
BE809832A
BE809832A BE139887A BE139887A BE809832A BE 809832 A BE809832 A BE 809832A BE 139887 A BE139887 A BE 139887A BE 139887 A BE139887 A BE 139887A BE 809832 A BE809832 A BE 809832A
Authority
BE
Belgium
Prior art keywords
treatment
pharmaceutical compositions
skin diseases
diseases
skin
Prior art date
Application number
BE139887A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE809832A publication Critical patent/BE809832A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE139887A 1973-01-16 1974-01-16 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES BE809832A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32401273A 1973-01-16 1973-01-16
US42506573A 1973-12-17 1973-12-17

Publications (1)

Publication Number Publication Date
BE809832A true BE809832A (en) 1974-07-16

Family

ID=26984233

Family Applications (1)

Application Number Title Priority Date Filing Date
BE139887A BE809832A (en) 1973-01-16 1974-01-16 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES

Country Status (3)

Country Link
BE (1) BE809832A (en)
DE (1) DE2401446A1 (en)
FR (1) FR2213776A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1172565A (en) * 1980-04-25 1984-08-14 Alfred Boris Anti-inflammatory methods and compositions
US4444780A (en) * 1982-08-30 1984-04-24 Ortho Pharmaceutical Corporation Method for treating atopic dermatitis
WO1991007177A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
US5461056A (en) * 1992-05-08 1995-10-24 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
WO2008154389A1 (en) * 2007-06-06 2008-12-18 Human Matrix Sciences Llc Aldosterone induced elastin production
WO2009149441A1 (en) 2008-06-06 2009-12-10 Human Matrix Sciences Llc Aldosterone induced vascular elastin production

Also Published As

Publication number Publication date
FR2213776A1 (en) 1974-08-09
DE2401446A1 (en) 1974-07-25

Similar Documents

Publication Publication Date Title
FR2316954A1 (en) DENTAL PREPARATION FOR THE TREATMENT OF PERIODONTOSIS
SE7512274L (en) PHARMACEUTICAL COMPOSITION FOR TOPIC TREATMENT OF SKIN
BE778149A (en) NEW PRODUCTS FOR THE TREATMENT AND HYGIENE OF THE SKIN
BE865156A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DEPRESSIONS
BE793792A (en) COMPOSITIONS FOR THE TREATMENT OF THE SKIN
CH428100A (en) Composition for the treatment and care of the skin
FR2291740A1 (en) PREPARATION FOR THE TREATMENT OF HAIR AND SKIN
BE809832A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES
BE809831A (en) PHARMACEUTICAL COMPOSITIONS FOR TREATING SKIN DISEASES
BE821888A (en) TREATMENT OF DROP DISPERSIONS
BE815825A (en) COMPOSITION FOR THE TREATMENT OF THE SKIN
FR2310769A1 (en) MEDICINAL PRODUCT FOR THE TREATMENT OF ALOPECIA SEBORRHOEICA
BE814735A (en) NEW PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEART DISEASE
BE809834A (en) TREATMENT COMPOSITONS FOR SKIN DISEASES
BE809833A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PROLIFERANT SKIN DISEASES
BE771357A (en) COMPOSITION FOR THE BACTERICIDAL TREATMENT OF ISOLATED AREAS OF HUMAN SKIN AND FOR THE TREATMENT OF SKIN AFFECTIONS.
FR2311553A1 (en) MEDICINE FOR THE TREATMENT OF SCHIZOPHRENIA
BE854412A (en) PHARMACEUTICAL COMPOSITIONS FOR GYNECOLOGICAL TREATMENT
BE820222A (en) THERAPEUTIC COMPOSITION FOR THE TREATMENT OF ORAL DIABETES
BE809835A (en) COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES
BE837294A (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CIRCULATION DISORDERS
FR2310770A1 (en) MEDICINAL PRODUCT FOR THE TREATMENT OF ALOPECIA AREATA
BE829024A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYDROPISIS
BE816170A (en) OXYGENIC HETEROCYCLIC DERIVATIVES FOR USE AS MEDICINAL PRODUCTS FOR THE TREATMENT OF DELAYED HYPERSENSITIVITY
BE817252A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEPATIC DISEASES